Pediatrix Medical Group I... (MD)
NYSE: MD
· Real-Time Price · USD
13.53
0.05 (0.38%)
At close: Jun 25, 2025, 11:34 AM
Pediatrix Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Health Care, Patient Service Revenue | 1.72B | 1.72B | 1.69B | 1.64B | 1.48B | 3.09B | 3.07B |
| Health Care, Patient Service Revenue Growth | +0.42% | +1.63% | +2.89% | +10.80% | -52.09% | +0.79% | n/a |
| Hospitals Contracts Revenue | 286.68M | 275.68M | 262.93M | 240.02M | 218.5M | 396.81M | 363.37M |
| Hospitals Contracts Revenue Growth | +3.99% | +4.85% | +9.54% | +9.85% | -44.94% | +9.20% | n/a |
| Product and Service, Other Revenue | 2.63M | 2.6M | 20.27M | 29.85M | 34.13M | 24.74M | n/a |
| Product and Service, Other Revenue Growth | +1.39% | -87.20% | -32.08% | -12.54% | +37.93% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 58.6M | 63.55M | 58.12M | 56.56M | 60.2M | 53.06M | 57.41M | 58.01M | 59.06M | 51.06M | 57.89M | 61.16M | 61.29M | 58.98M | 66.89M | 70.97M | 66.52M | 54.67M | 66.35M | 77.67M | 105.23M | 96.93M | 102.36M | 103.54M | 101.82M | 112.79M | 102.91M | 107.91M | 108.78M | 108.89M | 101.43M | 103.02M | 103.77M | 97.05M | 93.46M | 92.12M | 89.95M | 85.39M | 80.19M | 72.4M | 67.94M |
| Selling, General, and Administrative Revenue Growth | -7.79% | +9.35% | +2.75% | -6.04% | +13.44% | -7.56% | -1.05% | -1.77% | +15.67% | -11.80% | -5.36% | -0.20% | +3.91% | -11.83% | -5.74% | +6.69% | +21.67% | -17.60% | -14.58% | -26.19% | +8.57% | -5.31% | -1.14% | +1.69% | -9.72% | +9.60% | -4.64% | -0.80% | -0.11% | +7.36% | -1.54% | -0.72% | +6.92% | +3.84% | +1.46% | +2.41% | +5.34% | +6.49% | +10.75% | +6.57% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |